- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Eltrombopag olamine – November 2010
Eltrombopag olamine, tablets, 25 mg and 50 mg, Revolade®
Last updated
17 March 2011